# Viking Therapeutics, Inc. (VKTX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/VKTX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -158.33M | $ -113.98M | $ 0 | $ 501.92M |
| 2025 | $ 0 | $ -368.24M | $ -285.35M | $ 137.0K | $ 639.06M |
| 2024 | $ 0 | $ -115.58M | $ -92.27M | $ 1.12M | $ 880.28M |
| 2023 | $ 0 | $ -92.87M | $ -79.34M | $ 1.26M | $ 348.42M |
| 2022 | $ 0 | $ -76.93M | $ -54.06M | $ 1.56M | $ 145.32M |
| 2021 | $ 0 | $ -65.36M | $ -56.56M | $ 29.0K | $ 201.88M |
| 2020 | $ 0 | $ -50.31M | $ -27.74M | $ 359.0K | $ 244.34M |
| 2019 | $ 0 | $ -33.27M | $ -31.95M | $ 662.0K | $ 277.12M |
| 2018 | $ 0 | $ -29.14M | $ -24.77M | $ 0 | $ 297.75M |
| 2017 | $ 0 | $ -27.72M | $ -19.88M | $ 3.45M | $ 13.46M |
| 2016 | $ 0 | $ -20.27M | $ -15.23M | $ 3.27M | $ 8.04M |
| 2015 | $ 0 | $ -32.86M | $ -12.26M | $ 2.15M | $ 8.72M |
| 2014 | $ 0 | $ -30.92M | $ -2.25M | $ 1.57M | $ -22.13M |
| 2013 | $ 0 | $ -208.0K | $ -111.3K | $ 278.7K | $ -250.6K |
| 2012 | $ 0 | $ -160.3K | $ -72.2K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.21 |
| Current Ratio | 5.72 |

## Other views

- [Metrics](https://sponda.capital/en/VKTX.md)
- [Charts](https://sponda.capital/en/VKTX/charts.md)
- [Compare](https://sponda.capital/en/VKTX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.